Alaunos Therapeutics (TCRT) Revenue (2011 - 2025)
Alaunos Therapeutics' (TCRT) quarterly Revenue came in at $3000.0 in Q4 2025, down 25.0% YoY from $4000.0 in Q4 2024, and up 50.0% on a QoQ basis from $2000.0 in Q1 2025.
Alaunos Therapeutics (TCRT) Revenue (2011 - 2025) Analysis & Trends
Alaunos Therapeutics (TCRT) has 13 years of Revenue data on file, last reported at $3000.0 in Q4 2025.
- Quarterly Revenue fell 25.0% year-over-year to $3000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $3000.0 (down 70.0% YoY) and the FY2025 annual result came in at $5000.0, down 50.0% from the prior year.
- Revenue grew to $3000.0 in Q4 2025, from $2000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.9 million in Q3 2022 to a low of -$11000.0 in Q4 2022.
- A 5-year average of $301727.3 and a median of $3000.0 in 2025 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 631.41% in 2022, down 650.0% in 2022.
- Tracing TCRT's Revenue over 5 years: stood at $2000.0 in 2021, then slumped by 650.0% to -$11000.0 in 2022, then jumped by 109.09% to $1000.0 in 2023, then jumped by 300.0% to $4000.0 in 2024, then retreated by 25.0% to $3000.0 in 2025.
- The last three Revenue figures came in at $3000.0 (Q4 2025), $2000.0 (Q1 2025), and $4000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Alaunos Therapeutics | 4.33 Mn | 4.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Dec 31, 2022 | -11,000.00 |
| Sep 30, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 398,000.00 |
| Mar 31, 2018 | 146,000.00 |
| Dec 31, 2017 | 1.60 Mn |
| Sep 30, 2017 | 1.60 Mn |
| Jun 30, 2017 | 1.60 Mn |
| Mar 31, 2017 | 1.60 Mn |
| Dec 31, 2016 | 1.60 Mn |
| Sep 30, 2016 | 1.60 Mn |
| Jun 30, 2016 | 1.70 Mn |
| Mar 31, 2016 | 1.97 Mn |